Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Indian Pharmaceuticals Market continued to report mid-single digit growth on year on year basis in October. IPM sales grew by ...

DelveInsight's Glucose Syrup Market Insights report provides the current and forecast market analysis, individual leading ...

The Saudi Arabia Pharmaceutical Drugs market has been expanding significantly in recent years, driven by various key factors like increased demand for its products, expanding customer base, and ...

The glucose syrup market is largely driven by its rising demand within the food and beverage industry. Furthermore, the expanding uses and benefits of glucose syrup in the pharmaceutical sector ...

Trent Ltd, a Tata Group retail firm ... while revenue rose marginally to Rs 1,118 crore. Consumer products revenue increased, while lighting solutions revenue ...

Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...

News for Natco Pharma Ltd. Mylan Settles Patent Suit with Novo Nordisk over Generic Ozempic Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement in the US over a patent infringement ...